| HOME >> BIOLOGY >> TECHNOLOGY |
Net income available
to common shareholders $182 $ - $ - $72 $254
Diluted earnings
per common share:
Earnings available to
common shareholders
before cumulative
effect of a change
in accounting
principle $ 0.12 $0.17
Cumulative effect of
a change in
accounting principle,
net of tax - -
Diluted earnings
per common share $ 0.12 $0.17
Average common
shares outstanding
-diluted 1,497 1,497
SCHERING-PLOUGH CORPORATION
Reconciliation from Reported Net (Loss)/Income Available to Common Shareholders and Reported Diluted (Loss)/Earnings Per Common Share to As Reconciled Amounts for Net (Loss)/Income
Available to Common Shareholders and Diluted (Loss)/Earnings per Common
Share (unaudited)
(Amounts in Millions, except per share figures)
Twelve months ended December 31, 2007
Purchase Acquisition- Other
As Accounting Related Specified As
Reported Adjustments Items Items Reconciled
Net sales $12,690 $ - $ - $ - $12,690
Cost of sales 4,405 (326) - - 4,079
Selling, general
and administrative 5,468 - - - 5,468
Research and
development 2,926 - - (197) 2,729
Acquired in-process
research and
development 3,754 (3,754) - - -
Other (income)/
expense, net (683) - 537 -
'/>"/>
| SOURCE Schering-Plough Corporation Copyright©2008 PR Newswire. All rights reserved |